VST BIO Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Monoclonal Antibody to Treat Ischemic Stroke at AHA International Stroke Conference

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

VST-Bio-Corp-study-UK

More Like This

PR Newswire associated0

Simcere Phar-maceuticals Presented Six Studies on Sanbexin® at ESOC 2024

PR Newswire associated0

A major advance on stroke at Montpellier University Hospital published in the New England Journal of Medicine

XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke

PR Newswire associated0

Brainomix Announces New Studies Further Validating the Impact of Brainomix 360 Stroke Platform

Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis

SpikImm Announces the Signature of an Exclusive License Option and Collaboration Agreement With SATT Conectus for the Development of a Prophylactic Treatment Against the BK Virus, Causing Severe Complications in Transplant Patients

PR Newswire associated0

New Study Shows Brainomix 360 AI Transforms Stroke Treatment in England

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress